Literature DB >> 26859277

Successful Use of Single Doses of Granulocyte-Colony Stimulating Factor (G-CSF) in the Treatment of Late-Onset Agranulocytosis Associated With Clozapine in a Patient With Treatment-Resistant Schizophrenia: A Case Report.

Carla Comacchio1, Nicola Dusi, Antonio Lasalvia.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26859277     DOI: 10.1097/JCP.0000000000000467

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN: 0271-0749            Impact factor:   3.153


× No keyword cloud information.
  2 in total

1.  Changes for clozapine monitoring in the United States.

Authors:  T Bastiampillai; A Gupta; S K W Chan; S Allison
Journal:  Mol Psychiatry       Date:  2016-05-03       Impact factor: 15.992

2.  Utilization of G-CSF and GM-CSF as an alternative to discontinuation in clozapine-induced neutropenia or leukopenia: A case report and discussion.

Authors:  Allison Karst; Jonathan Lister
Journal:  Ment Health Clin       Date:  2018-08-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.